Business

March 10, 2014

Gillings and other Quintiles investors hope to cash out

Dennis Gillings, co-founder and chairman of pharmaceutical services giant Quintiles, could reap more than $200 million by selling a chunk of his holdings in the Durham-based company.

Related content

Comments

Videos

Editor's Choice Videos